← Back to Search

BIXINK OC Free for Obsessive-Compulsive Disorder

Spectrum Neuroscience and Treatment Institute, New York, NY
Targeting 2 different conditionsBIXINK OC FreeN/ARecruitingLed by Eric Hollander, MDResearch Sponsored by BIXINK Therapeutics Co., Ltd.

Study Summary

This trial is testing a new app to help people with OCD who are also receiving outpatient therapy. The app provides treatment via computerized exposure and response prevention, and the trial will evaluate its safety and effectiveness.

Eligible Conditions
  • Obsessive-Compulsive Disorder

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You have a certain level of severity in your symptoms, as determined by a rating scale called the CGI-Severity score.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~endpoint (week 6), follow-up (week 10)
This trial's timeline: 3 weeks for screening, Varies for treatment, and endpoint (week 6), follow-up (week 10) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Yale-Brown Obsessive-Compulsive Scale (Y-BOCs)
Secondary outcome measures
Beck Anxiety Inventory
Mental Depression
Clinical Global Impression - Improvement scale (CGI-I)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: BIXINK OC FreeExperimental Treatment1 Intervention
A 6 week ERP-based intervention

Find a Location

Who is running the clinical trial?

BIXINK Therapeutics Co., Ltd.Lead Sponsor
Eric Hollander, MDPrincipal InvestigatorSpectrum Neuroscience and Treatment Institute
16 Previous Clinical Trials
619 Total Patients Enrolled
2 Trials studying Obsessive-Compulsive Disorder
187 Patients Enrolled for Obsessive-Compulsive Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New Jersey
New York
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
What site did they apply to?
Spectrum Neuroscience and Treatment Institute
How many prior treatments have patients received?
1

Why did patients apply to this trial?

Have been struggling with trichotillomania for 5 years. This is the most obvious manifestation of my OCD as well as obsessive thoughts and rumination.
PatientReceived 1 prior treatment

How responsive is this trial?

Typically responds via
Phone Call
Most responsive sites:
  1. Spectrum Neuroscience and Treatment Institute: < 24 hours
Average response time
  • < 1 Day
Recent research and studies
clinicaltrials.govStudy
An ERP-based Mobile Intervention as an Adjunctive Treatment for OCD
2021. "An ERP-based Mobile Intervention as an Adjunctive Treatment for OCD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05166707.
All > Ocd
~10 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top